AGP Executive Report
Last update: 11 hours agoWater & Wellness Business: Dropvital (Dropvital AG, Schaan) is positioning itself as a trust-first water-treatment brand, combining hands-on filtration installation experience with certified organic medicinal mushroom know-how and manufacturer-independent service support. Cancer Drug Access: IMPACT Therapeutics and Pharmanovia signed an exclusive licensing deal for senaparib, aiming to expand the ovarian cancer maintenance therapy across 66 countries, including Liechtenstein and the wider EU/UK/EEA markets, with payments up to €423.5m plus royalties. Public Health Research: A new push for a “functional cure” for chronic hepatitis B highlights ongoing work across Europe, noting millions in the EU/EEA (including Liechtenstein) live with infection without realizing it until serious liver damage. Patient Safety & Supply Chains: Ivoclar is rolling out a verification approach to reduce risks from counterfeit and gray-market dental products, warning that unofficial sourcing can mean expired or improperly handled materials. Local Policy Watch: Liechtenstein’s abortion law debate is resurfacing, with reporting focused on the role of Hereditary Prince Alois and the impact on access for people who would otherwise travel to Switzerland or Austria.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
